HETEROCYCLIC COMPOUND AND USE THEREOF

HETEROCYCLIC COMPOUND AND USE THEREOF

The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TAKEUCHI, Kohei, TOKUNAGA, Norihito, MIYAZAKI, Tohru, ODA, Tsuneo, MIYANOHANA, Yuhei, SUGIMOTO, Takahiro, HATTORI, Yasushi, IMAMURA, Keisuke, UYGHUR, Dilhumar, HOASHI, Yasutaka, KOIKE, Tatsuki, KAJITA, Yuichi, ITO, Yoshiteru
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TAKEUCHI, Kohei
TOKUNAGA, Norihito
MIYAZAKI, Tohru
ODA, Tsuneo
MIYANOHANA, Yuhei
SUGIMOTO, Takahiro
HATTORI, Yasushi
IMAMURA, Keisuke
UYGHUR, Dilhumar
HOASHI, Yasutaka
KOIKE, Tatsuki
KAJITA, Yuichi
ITO, Yoshiteru
description The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2021198240A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2021198240A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2021198240A13</originalsourceid><addsrcrecordid>eNrjZFD1cA1xDfJ3jnT28XRWcPb3DfAP9XNRcATi0GBXhRAP1yBXfzceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGRoaGlhZGLgaGhMnCoALNckKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLIC COMPOUND AND USE THEREOF</title><source>esp@cenet</source><creator>TAKEUCHI, Kohei ; TOKUNAGA, Norihito ; MIYAZAKI, Tohru ; ODA, Tsuneo ; MIYANOHANA, Yuhei ; SUGIMOTO, Takahiro ; HATTORI, Yasushi ; IMAMURA, Keisuke ; UYGHUR, Dilhumar ; HOASHI, Yasutaka ; KOIKE, Tatsuki ; KAJITA, Yuichi ; ITO, Yoshiteru</creator><creatorcontrib>TAKEUCHI, Kohei ; TOKUNAGA, Norihito ; MIYAZAKI, Tohru ; ODA, Tsuneo ; MIYANOHANA, Yuhei ; SUGIMOTO, Takahiro ; HATTORI, Yasushi ; IMAMURA, Keisuke ; UYGHUR, Dilhumar ; HOASHI, Yasutaka ; KOIKE, Tatsuki ; KAJITA, Yuichi ; ITO, Yoshiteru</creatorcontrib><description>The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210701&amp;DB=EPODOC&amp;CC=US&amp;NR=2021198240A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210701&amp;DB=EPODOC&amp;CC=US&amp;NR=2021198240A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAKEUCHI, Kohei</creatorcontrib><creatorcontrib>TOKUNAGA, Norihito</creatorcontrib><creatorcontrib>MIYAZAKI, Tohru</creatorcontrib><creatorcontrib>ODA, Tsuneo</creatorcontrib><creatorcontrib>MIYANOHANA, Yuhei</creatorcontrib><creatorcontrib>SUGIMOTO, Takahiro</creatorcontrib><creatorcontrib>HATTORI, Yasushi</creatorcontrib><creatorcontrib>IMAMURA, Keisuke</creatorcontrib><creatorcontrib>UYGHUR, Dilhumar</creatorcontrib><creatorcontrib>HOASHI, Yasutaka</creatorcontrib><creatorcontrib>KOIKE, Tatsuki</creatorcontrib><creatorcontrib>KAJITA, Yuichi</creatorcontrib><creatorcontrib>ITO, Yoshiteru</creatorcontrib><title>HETEROCYCLIC COMPOUND AND USE THEREOF</title><description>The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD1cA1xDfJ3jnT28XRWcPb3DfAP9XNRcATi0GBXhRAP1yBXfzceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGRoaGlhZGLgaGhMnCoALNckKg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>TAKEUCHI, Kohei</creator><creator>TOKUNAGA, Norihito</creator><creator>MIYAZAKI, Tohru</creator><creator>ODA, Tsuneo</creator><creator>MIYANOHANA, Yuhei</creator><creator>SUGIMOTO, Takahiro</creator><creator>HATTORI, Yasushi</creator><creator>IMAMURA, Keisuke</creator><creator>UYGHUR, Dilhumar</creator><creator>HOASHI, Yasutaka</creator><creator>KOIKE, Tatsuki</creator><creator>KAJITA, Yuichi</creator><creator>ITO, Yoshiteru</creator><scope>EVB</scope></search><sort><creationdate>20210701</creationdate><title>HETEROCYCLIC COMPOUND AND USE THEREOF</title><author>TAKEUCHI, Kohei ; TOKUNAGA, Norihito ; MIYAZAKI, Tohru ; ODA, Tsuneo ; MIYANOHANA, Yuhei ; SUGIMOTO, Takahiro ; HATTORI, Yasushi ; IMAMURA, Keisuke ; UYGHUR, Dilhumar ; HOASHI, Yasutaka ; KOIKE, Tatsuki ; KAJITA, Yuichi ; ITO, Yoshiteru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2021198240A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKEUCHI, Kohei</creatorcontrib><creatorcontrib>TOKUNAGA, Norihito</creatorcontrib><creatorcontrib>MIYAZAKI, Tohru</creatorcontrib><creatorcontrib>ODA, Tsuneo</creatorcontrib><creatorcontrib>MIYANOHANA, Yuhei</creatorcontrib><creatorcontrib>SUGIMOTO, Takahiro</creatorcontrib><creatorcontrib>HATTORI, Yasushi</creatorcontrib><creatorcontrib>IMAMURA, Keisuke</creatorcontrib><creatorcontrib>UYGHUR, Dilhumar</creatorcontrib><creatorcontrib>HOASHI, Yasutaka</creatorcontrib><creatorcontrib>KOIKE, Tatsuki</creatorcontrib><creatorcontrib>KAJITA, Yuichi</creatorcontrib><creatorcontrib>ITO, Yoshiteru</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAKEUCHI, Kohei</au><au>TOKUNAGA, Norihito</au><au>MIYAZAKI, Tohru</au><au>ODA, Tsuneo</au><au>MIYANOHANA, Yuhei</au><au>SUGIMOTO, Takahiro</au><au>HATTORI, Yasushi</au><au>IMAMURA, Keisuke</au><au>UYGHUR, Dilhumar</au><au>HOASHI, Yasutaka</au><au>KOIKE, Tatsuki</au><au>KAJITA, Yuichi</au><au>ITO, Yoshiteru</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLIC COMPOUND AND USE THEREOF</title><date>2021-07-01</date><risdate>2021</risdate><abstract>The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2021198240A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title HETEROCYCLIC COMPOUND AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A13%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAKEUCHI,%20Kohei&rft.date=2021-07-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2021198240A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true